April 18th, 2025
Coronavirus Updates - Page 12
Elon Musk Calls COVID-19 Pandemic ‘Practice Run’ for Future Viruses
By Steve Muchoki
May 8th, 2020
During an interview with comedian Joe Rogan, Tesla CEO Elon Musk commented on a number of his recent sentiments, including his opinion about ongoing coronavirus ‘shelter in place’ policy.
Moderna (MRNA) Stock Rises 10% after FDA Approves mRNA-1273 Vaccine for Phase 2 Trial
By Darya Rudz
May 7th, 2020
Phase 2 trial of Moderna’s coronavirus vaccine will shortly begin and enroll 600 participants. The company is also planning to begin phase 3 trial as early as this summer. MRNA stock is 10% up now.
TSLA Stock Up 2% Yesterday, Slightly Down Now, Tesla Prepares to Reopen Fremont Factory
By Christopher Hamman
May 7th, 2020
Tesla (TSLA) stock price rose yesterday as reports emerged that Elon Musk plans to reopen its Fremont California factory this week. However, today TSLA stock is slightly down.
Gilead (GILD) Stock Rises 0.68% in Pre-Market as Japan Set to Approve Remdesivir Today
By Christopher Hamman
May 7th, 2020
Gilead (GILD) stock price is rising slightly after the Japanese government indicated that it could grant approval to its remdesivir drug to be used in the fight with COVID-19.
Lyft Stock Rises 16% as Company Reported Higher than Expected Q1 Revenue and Rider Number
By Christopher Hamman
May 7th, 2020
Lyft stock price started to rise yesterday after hours when the company revealed its Q1 report. The numbers are still not very impressive but Lyft is doing better than expected.
Peloton (PTON) Shares Up 15% in Pre-market, Sales Surge 66%, More People Buy Bikes Now
By Darya Rudz
May 7th, 2020
Peloton has seen a 66% surge in sales and generated $524.6 million in total revenue for the fiscal third quarter that ended on March 31. $98.2 million came from subscriptions, which is 92% higher year over year, and $420.2 million came from product sales, 61% up. PTON stock is up.
Inovio (INO) Pharmaceuticals Stock Fell 5% as Class Action Lawsuit Brews
By Tolu Ajiboye
May 6th, 2020
Inovio Pharmaceuticals might see a plunge in its 2020 gains if a class action lawsuit proves the company deliberately misled the public. Yesterday, INO stock lost over 5% of its value.
Investors Now Worry More about U.S.-China Deal Development Than about Coronavirus
By Teuta Franjkovic
May 6th, 2020
The phase one trade deal requires China to buy an additional $200 billion worth of U.S. products and services over the next two years compared to 2017 levels. However, the global pandemic has made it extremely unlikely that China will be able to fulfill its promises.
PFE Stock Up 2.37%, Pfizer Begins Human Trials of Its COVID-19 Vaccine Candidate in U.S.
By Darya Rudz
May 6th, 2020
On Monday, Pfizer announced it had dosed the first participants of the Phase 1/2 clinical trial for the coronavirus vaccine program in the U.S. In general, there will be 360 healthy patients dosed with the vaccine. PFE stock price is rising.
Fujifilm to Send Its Coronavirus Drug Favipiravir to Over 40 Countries for Trials
By Steve Muchoki
May 5th, 2020
Fujifilm (FUJIY) shares closed with a 0.95% rise yesterday after the company confirmed it will send its favipiravir coronavirus drug to over 40 countries for trials.
U.S. Treasury Is Going to Borrow $3 Trillion in Q2 2020
By Teuta Franjkovic
May 5th, 2020
The U.S. Treasury Department announced its plans to borrow about $3 trillion this quarter. The money is being used in large part to support the economy in the wake of the coronavirus pandemic.
Gilead (GILD) Stock Up Less Than 1% Yesterday, WHO to Make Remdesivir Widely Available
By Steve Muchoki
May 5th, 2020
Gilead Sciences (GILD) stock closed yesterday with a 0.38% rise to trade at $80.25. WHO wants to involve the U.S. government in making remdesivir globally available.
Moderna (MRNA) Stock Price Up 4% as Trump Talks about Possible COVID-19 Vaccine This Year
By Christopher Hamman
May 4th, 2020
Moderna (MRNA) stock price is up as U.S. President Donald Trump has indicated that there could be a working COVID-19 vaccine by the end of the year.
GILD Stock Up 3% Now, Gilead’s Remdesivir to be Available to U.S. Hospitals This Week
By Darya Rudz
May 4th, 2020
Following the Gilead CEO’s statement about exporting remdesivir to the U.S. hospitals, Gilead Sciences (GILD) stock is up. In the pre-market today, Gilead shares are over 3% up, trading at above $82.
MRNA Stock Up 2%, Moderna Signs Deal to Ramp Up 1B COVID-19 Vaccine Doses a Year
By Steve Muchoki
May 1st, 2020
Moderna is moving forward with its coronavirus vaccine. The company announced a deal with Lonza Group AG to manufacture 1 billion coronavirus vaccine doses a year. MRNA stock is up.